| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 212.77B | 215.79B | 259.01B | 260.30B | 229.13B |
| Gross Profit | 29.76B | 27.54B | 29.23B | 29.48B | 26.15B |
| EBITDA | 6.04B | 7.34B | 9.14B | 8.98B | 7.73B |
| Net Income | 5.28B | 4.70B | 5.74B | 5.37B | 5.00B |
Balance Sheet | |||||
| Total Assets | 154.30B | 142.00B | 156.03B | 152.66B | 142.35B |
| Cash, Cash Equivalents and Short-Term Investments | 33.59B | 33.31B | 19.32B | 11.80B | 11.64B |
| Total Debt | 2.24B | 2.69B | 4.01B | 4.23B | 844.00M |
| Total Liabilities | 59.77B | 52.78B | 68.94B | 72.76B | 67.59B |
| Stockholders Equity | 94.52B | 89.20B | 87.08B | 79.90B | 74.77B |
Cash Flow | |||||
| Free Cash Flow | 4.88B | 18.22B | 9.41B | -2.75B | -8.06B |
| Operating Cash Flow | 6.07B | 18.45B | 9.94B | -199.00M | -7.62B |
| Investing Cash Flow | -2.98B | -15.00M | -710.00M | -1.25B | -1.33B |
| Financing Cash Flow | -3.00B | -4.20B | -2.28B | -115.00M | -883.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥74.02B | 8.02 | ― | 2.87% | 50.78% | 26.58% | |
73 Outperform | ¥72.34B | 9.45 | 5.37% | 3.41% | -1.40% | 13.91% | |
71 Outperform | ¥544.93B | 14.85 | ― | 2.87% | 17.41% | 10.46% | |
66 Neutral | ¥613.90B | 90.12 | ― | 0.79% | 3.53% | -18.43% | |
63 Neutral | ¥35.16B | 17.69 | ― | 3.02% | 8.81% | 11.05% | |
62 Neutral | ¥95.90B | 7.40 | ― | 2.41% | 50.28% | 79.25% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |